| abstract |
As used herein, to treat breast cancer by administering a compound, or a pharmaceutically acceptable salt thereof, and a therapeutically effective amount of a compound, or a pharmaceutically acceptable salt thereof, to a subject in need thereof. A method of using the compound is disclosed. The breast cancer may be ER positive breast cancer and / or the subject in need of treatment may express a mutant ER-α protein. [Selection figure] None |